Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ER-Negative PR-Negative HER2-Negative Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01514565
What this trial is testing

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Thomas Jefferson University 70
Testing effectiveness (Phase 2)Study completedNCT03289819
What this trial is testing

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC

Who this might be right for
Malignant Neoplasm of Breast
Institut fuer Frauengesundheit 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT01116648
What this trial is testing

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Who this might be right for
Fallopian Tube CarcinomaOvarian Endometrioid AdenocarcinomaOvarian High Grade Serous Adenocarcinoma+4 more
National Cancer Institute (NCI) 155
Testing effectiveness (Phase 2)UnknownNCT05953168
What this trial is testing

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

Who this might be right for
Triple-Negative Breast Cancer
Fudan University 69
Not applicableLooking for participantsNCT07327489
What this trial is testing

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Who this might be right for
CancerImmunotherapyAdvanced Solid Tumors Cancer+12 more
Elephas 2,000
Early research (Phase 1)Active Not RecruitingNCT05537740
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 129
Testing effectiveness (Phase 2)Looking for participantsNCT05491226
What this trial is testing

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
Stephen Shiao 35
Not applicableStudy completedNCT04368468
What this trial is testing

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

Who this might be right for
Triple Negative Breast Cancer
Institut Claudius Regaud 100
Testing effectiveness (Phase 2)Study completedNCT02834403
What this trial is testing

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Who this might be right for
Metastatic Triple Negative Breast Cancer
The Methodist Hospital Research Institute 37
Testing effectiveness (Phase 2)Study completedNCT00691379
What this trial is testing

Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 46
Testing effectiveness (Phase 2)Looking for participantsNCT05902988
What this trial is testing

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more
Volastra Therapeutics, Inc. 200
Testing effectiveness (Phase 2)Study completedNCT03464942
What this trial is testing

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Peter MacCallum Cancer Centre, Australia 54
Testing effectiveness (Phase 2)Ended earlyNCT05180006
What this trial is testing

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 33
Testing effectiveness (Phase 2)UnknownNCT03932526
What this trial is testing

Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Liaoning Cancer Hospital & Institute 184
Testing effectiveness (Phase 2)Study completedNCT04592484
What this trial is testing

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Who this might be right for
Advanced Solid Tumor
Codiak BioSciences 27
Testing effectiveness (Phase 2)Ended earlyNCT04986852
What this trial is testing

Olinvacimab With Pembrolizumab in Patients With mTNBC

Who this might be right for
Metastatic Triple-Negative Breast Cancer
PharmAbcine 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT07471815
What this trial is testing

Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy

Who this might be right for
Breast Cancer Triple Negative Breast Cancer
Harbin Medical University 30
Not applicableNot Yet RecruitingNCT07523789
What this trial is testing

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 201
Early research (Phase 1)Study completedNCT01281150
What this trial is testing

Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid NeoplasmEstrogen Receptor NegativeEstrogen Receptor Positive+8 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)WithdrawnNCT02539017
What this trial is testing

The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
First Affiliated Hospital Xi'an Jiaotong University
Next Page